Post Transplant Donor Lymphocyte Infusion

NCT00167180 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

57

Enrollment

OTHER

Sponsor class

Stopped Accrual Goal Met

Conditions

Leukemia, Myeloid, Chronic
Lymphomas
Multiple Myeloma
Myelodysplastic Syndrome
Leukemia, Lymphocytic, Acute
Leukemia, Lymphocytic, Chronic
AML

Interventions

PROCEDURE: Donor Lymphocyte Infusion
DRUG: Induction Chemotherapy

Sponsor

Masonic Cancer Center, University of Minnesota